Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC)

Qianqian Zhu; Yanan Sun; Yingying Cui; Ke Ye; Chengliang Yang; Daoke Yang; Jie Ma; Xiao Liu; Jinming Yu; Hong Ge

doi:10.18632/oncotarget.14515

Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC)

Oncotarget ◽

10.18632/oncotarget.14515 ◽

2017 ◽

Vol 8 (8) ◽

pp. 13304-13311 ◽

Cited By ~ 17

Author(s):

Qianqian Zhu ◽

Yanan Sun ◽

Yingying Cui ◽

Ke Ye ◽

Chengliang Yang ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Clinical Outcome ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant

Download Full-text

HER3 ligand heregulin expression and clinical implication in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors

Annals of Oncology ◽

10.1093/annonc/mdz260.057 ◽

2019 ◽

Vol 30 ◽

pp. v630-v631

Author(s):

K. Yonesaka ◽

E. Iwama ◽

H. Hayashi ◽

S. Suzuki ◽

R. Kato ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors ◽

Epidermal Growth ◽

Egfr Mutant

Download Full-text

Atezolizumab and Bevacizumab in Epidermal Growth Factor Receptor (EGFR) Mutant Non‐Small Cell Lung Cancer in Patients With Progressive Disease After Receiving Osimertinib

Case Medical Research ◽

10.31525/ct1-nct04099836 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progressive Disease ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant

Download Full-text

135P The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC) patients

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01977-8 ◽

2021 ◽

Vol 16 (4) ◽

pp. S770-S771

Author(s):

J. Subramanian ◽

Y-L. Choi ◽

T-Y. Chou ◽

J. Gregg ◽

R. Hui ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Advanced Stage ◽

Small Cell Lung ◽

Epidermal Growth ◽

Nsclc Patients

Download Full-text

Real world prospective data on tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor mutation positive non-small cell lung cancer at the Edinburgh Cancer Centre

Lung Cancer ◽

10.1016/s0169-5002(21)00278-6 ◽

2021 ◽

Vol 156 ◽

pp. S32

Author(s):

Amanda Swan ◽

Zhuang Boh ◽

Ailsa Patrizio ◽

Iain Phillips ◽

Tamasin Evans ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Prospective Data ◽

Epidermal Growth

Download Full-text

A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome

Annals of Oncology ◽

10.1093/annonc/mdx426.006 ◽

2017 ◽

Vol 28 ◽

pp. vi56

Author(s):

I. Stasi ◽

A. Farnesi ◽

E. Vasile ◽

I. Petrini ◽

M. Luccchesi ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis

Download Full-text

Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance

memo - Magazine of European Medical Oncology ◽

10.1007/s12254-019-0488-3 ◽

2019 ◽

Vol 12 (2) ◽

pp. 128-135 ◽

Cited By ~ 1

Author(s):

Gudrun Absenger

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Targeted Therapies for Non-Small Cell Lung Cancer: An Update on Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Inhibitors

Clinical Journal of Oncology Nursing ◽

10.1188/15.cjon.734-742 ◽

2015 ◽

Vol 19 (6) ◽

pp. 734-742 ◽

Cited By ~ 3

Author(s):

Kristen Kreamer ◽

Debbie Riordan

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Epidermal Growth

Download Full-text

Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer

International Journal of Cancer ◽

10.1002/ijc.27403 ◽

2012 ◽

Vol 131 (3) ◽

pp. E227-E235 ◽

Cited By ~ 47

Author(s):

Fu-Tsai Chung ◽

Kang-Yun Lee ◽

Chih-Wei Wang ◽

Chih-Chen Heh ◽

Yao-Fei Chan ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors

Download Full-text

Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcome in Resected Non–Small Cell Lung Cancer Patients

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e31827a7e7a ◽

2014 ◽

Vol 37 (4) ◽

pp. 343-349 ◽

Cited By ~ 8

Author(s):

Mark Ragusa ◽

Jacopo Vannucci ◽

Vienna Ludovini ◽

Fortunato Bianconi ◽

Stefano Treggiari ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Clinical Outcome ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Kras Mutations ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/j.lungcan.2019.09.017 ◽

2019 ◽

Vol 137 ◽

pp. 113-122 ◽

Cited By ~ 15

Author(s):

Ana C.Z. Gelatti ◽

Alexander Drilon ◽

Fernando C. Santini

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text